(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)
Pathology of lung cancers is presented, along with targeted therapies current in 2010. Additionally, asbestosis, mesothelioma, and malignant lymphomas are presented with reference to their features, differential diagnoses, and prognosis. Topics include: Bronchioloalveolar carcinoma and minimally invasive adenocarcinoma; Neuroendocrine tumors; Lung carcinoma staging problems; Targeted therapies in lung cancer; Benign and malignant mesothelial proliferations; Asbestos related lung disease; Primary Lymphoproliferative diseases of the lung; Vasculitis; and Small airway disease.
Elsevier is a leading publisher of health science books and journals, helping to advance medicine by delivering superior education, reference information and decision support tools to doctors, nurses, health practitioners and students. With titles available across a variety of media—print, online and mobile, we are able to supply the information you need in the most convenient format.